Uncovering potential targets for MRSA infection treatment: a nanomedicine perspective
Targeting MRSA's virulence pathways through nanocarrier systems offers a paradigm shift beyond traditional antibiotics. The next decade will require not only optimization and mechanistic validation but also innovative material design, scalable manufacturing, and integration into clinical practice to realize the promise of nanocarrier-enabled anti-MRSA therapies.
Authors
- Mohammed A. Gafar (ORCID: https://orcid.org/0000-0003-3243-2468)
- Eman Abdel Rahman Ismail (ORCID: https://orcid.org/0000-0002-1162-0171)
- Relebohile Mautsoe (ORCID: https://orcid.org/0000-0002-2417-7252)
- Vincent O. Nyandoro (ORCID: https://orcid.org/0009-0002-3212-4115)
- Abdelrahman Tageldin
- Calvin A. Omolo
Institutions
- University of Khartoum (SD)
- Kabarak University (KE)
- University of Africa (ZM)
- University of Gezira (SD)
- Africa University (ZW)
- University of KwaZulu-Natal (ZA)
Publication Details
- Journal
- Expert Opinion on Therapeutic Targets
- Published
- 2026-01-02
- DOI
- https://doi.org/10.1080/14728222.2026.2620600
- Primary Topic
- Nanoparticles: synthesis and applications
- Type
- article
- Field-Weighted Citation Impact
- 0.00